Statistics
Publications
1
Citations
12
H-Index
1
Active since
2025
Affiliations
Johnson & Johnson (United States)(Current)
Raul Hernan Gabriel Ceitlin is an author at Johnson & Johnson (United States) specializing in immunotherapy, interleukin-23 inhibitors, and cytokine-based therapy.
Publications per year
2025–2025
1
1
Targeted Oral Peptide Icotrokinra for Psoriasis Involving High-Impact Sites
Melinda Gooderham, Edward Lain, Robert Bissonnette et al. · NEJM Evidence · 2025 · 12 citations
1–1 of 1